BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1569 related articles for article (PubMed ID: 16855634)

  • 1. International uniform response criteria for multiple myeloma.
    Durie BG; Harousseau JL; Miguel JS; Bladé J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Cavo M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV;
    Leukemia; 2006 Sep; 20(9):1467-73. PubMed ID: 16855634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
    Rajkumar SV; Buadi F
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma: charging toward a bright future.
    Katzel JA; Hari P; Vesole DH
    CA Cancer J Clin; 2007; 57(5):301-18. PubMed ID: 17855486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
    Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
    Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
    Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Nunzi M; Grasso M; Falco P; Cangialosi C; Boccadoro M
    Cancer; 2005 Oct; 104(7):1428-33. PubMed ID: 16116606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the management of multiple myeloma.
    Kumar L; Verma R; Radhakrishnan VR
    Natl Med J India; 2010; 23(4):210-8. PubMed ID: 21192514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma.
    van de Velde HJ; Liu X; Chen G; Cakana A; Deraedt W; Bayssas M
    Haematologica; 2007 Oct; 92(10):1399-406. PubMed ID: 18024376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
    Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
    Rajkumar SV; Dimopoulos MA; Palumbo A; Blade J; Merlini G; Mateos MV; Kumar S; Hillengass J; Kastritis E; Richardson P; Landgren O; Paiva B; Dispenzieri A; Weiss B; LeLeu X; Zweegman S; Lonial S; Rosinol L; Zamagni E; Jagannath S; Sezer O; Kristinsson SY; Caers J; Usmani SZ; Lahuerta JJ; Johnsen HE; Beksac M; Cavo M; Goldschmidt H; Terpos E; Kyle RA; Anderson KC; Durie BG; Miguel JF
    Lancet Oncol; 2014 Nov; 15(12):e538-48. PubMed ID: 25439696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response evaluation and monitoring of multiple myeloma.
    Fernández de Larrea C; Delforge M; Davies F; Bladé J
    Expert Rev Hematol; 2014 Feb; 7(1):33-42. PubMed ID: 24483347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
    Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
    Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
    Lee CK; Barlogie B; Zangari M; Fassas A; Anaissie E; Morris C; Van Rhee F; Cottler-Fox M; Thertulien R; Muwalla F; Mazher S; Badros A; Tricot G
    Bone Marrow Transplant; 2002 Dec; 30(12):873-8. PubMed ID: 12476279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study.
    Morris C; Iacobelli S; Brand R; Bjorkstrand B; Drake M; Niederwieser D; Gahrton G;
    J Clin Oncol; 2004 May; 22(9):1674-81. PubMed ID: 15037597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
    O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
    Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.